Cargando…
Progress in Using Circulating Tumor Cell Information to Improve Metastatic Breast Cancer Therapy
Circulating tumor cells (CTCs) were discovered nearly 150 years ago but have only recently been recognized as a feature of most solid tumors due to their extremely low concentration in the peripheral circulation. Several technologies have been developed to isolate and analyze CTCs, which can now be...
Autores principales: | Alemar, Jose, Schuur, Eric R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621388/ https://www.ncbi.nlm.nih.gov/pubmed/23589716 http://dx.doi.org/10.1155/2013/702732 |
Ejemplares similares
-
Circulating Tumor Cell Data: Integration with Imaging and Serum Tumor Markers for Metastatic Breast Cancer Patient Management
por: Marsland, Thomas, et al.
Publicado: (2014) -
Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management
por: Goodman, Oscar, et al.
Publicado: (2014) -
In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease
por: Han, Mikyung, et al.
Publicado: (2020) -
The dynamic range of circulating tumor DNA in metastatic breast cancer
por: Heidary, Maryam, et al.
Publicado: (2014) -
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
por: Brisotto, Giulia, et al.
Publicado: (2020)